Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.

Thakur, Gunjan; Kumar, Vikas; Lee, Keun Woo; Won, Chungkil

Thakur, Gunjan; Kumar, Vikas; Lee, Keun Woo; Won, Chungkil.

Affiliation

Thakur G; Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Korea.
Kumar V; Division of Life Sciences, Department of Bio & Medical Big Data (BK4 Program), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Korea.
Lee KW; Division of Life Sciences, Department of Bio & Medical Big Data (BK4 Program), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Korea.
Won C; Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Korea.

Genes (Basel) ; 13(8)2022 08 11.

Article de En | MEDLINE | ID: mdl-36011337

Sujet(s)
Mots clés

G2019S mutation; LRRK2; Parkinson's disease; kinase inhibitors; neurodegeneration

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson / Maladies neurodégénératives Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Genes (Basel) Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google